Leonardo Furtado Freitas on CADASIL: Early Diagnosis Equals Better Management
Leonardo Furtado Freitas, Clinical Associate Professor of Neuroradiology at Florida International University, shared on LinkedIn:
”Just published!
Our case report on CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) highlights the critical role of MRI and genetic testing in diagnosing this underrecognized condition.
In this case, a 46-year-old woman presented with progressive gait disturbance, vertigo, and transient sensory symptoms.
MRI revealed hyperintense lesions in the temporal poles and external capsules, plus a lacunar infarct in the gangliocapsular region—classic imaging features of CADASIL!
Radiologists, always keep CADASIL in mind when facing unexplained white matter changes and early-onset strokes.
Early diagnosis equals better management.”
Read the full article here.
Article: Autosomal Dominant Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Authors: Vitor Hugo de Souza, Márcio Luís Duarte, Marcelo de Queiroz Pereira da Silva, Leonardo Furtado Freitas
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis